Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.

Biotechnology innovations are revolutionizing healthcare with AI, data science, and automation, leading to more precise and ...

" When you have women in leadership positions, cultures tend to become more inclusive, " Kawas observes. "These environments encourage team members to share opinions and take calculated risks." This ...

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

The biotech industry is on a stable growth path, owing to the integration of modern technologies and rapid drug discoveries.

Vir Biotechnology (NASDAQ:VIR – Get Free Report) is expected to be releasing its earnings data after the market closes on ...

The U.S. IPO activity looks sluggish amid the holiday-shortened week. Nevertheless, the week prior saw Texas-based cybersecurity firm SailPoint price its upsized IPO of 60M shares at a public offering ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that members of the executive team are scheduled to participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, ...

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price target dropped by research analysts at The ...

USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be ...